Search for:

The Cancer Letter on Facebook
The Cancer Letter on Twitter
The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home

About
Current Issue
- Past Issues
Podcast
- The Directors
Events
Job Board

Search for:

Home

About
Current Issue
- Past Issues
Podcast
- The Directors
Events
Job Board

Drugs & Targets

Drugs & Targets Free TCCL Archive

European Commission Approves Subcutaneous Rituximab

March 31, 2014

Vol.37 No.03

Posts navigation

Previous 1…201202

Trending Stories

Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.”
Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
Most Favored Nation drug pricing could put China on top
Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line

ABOUT

About The Cancer Letter

Accessibility Statement

SUBSCRIPTIONS

CONTACT

Submission guidelines

Advertise

Careers

SEE ALSO

Terms & Conditions

Scroll to top

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

SEARCH DATE

SEARCH TEXT

Cancel

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Password

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Username or Email

Password

Remember Me Forgot Password?

Site license subscribers:
Log in with your IP | Register a sponsored account